OmniAb Inc (OABI) Q3 2024 Earnings Call Highlights: Strong Program Growth Amid Revenue Challenges [Yahoo! Finance]
OmniAb, Inc. (OABI)
Company Research
Source: Yahoo! Finance
OmniAb Inc ( NASDAQ:OABI ) reported strong growth in active programs, with 39 new additions and only 12 terminations, indicating robust interest in their technology. The company signed three new platform license agreements with notable institutions, including 92 Bio, Memorial Sloan Kettering Cancer Center, and Queen Mary University of London. OmniAb Inc ( NASDAQ:OABI ) expanded its ion channel screening relationship with Syngenta and entered a new license with Insight Corporation, showcasing successful business development efforts. The company has a diversified base of 86 active partners, which helps mitigate risks associated with industry cycles. OmniAb Inc ( NASDAQ:OABI ) maintains a strong financial position with $59.4 million in cash, providing strategic flexibility and resilience against macroeconomic pressures. Total revenue for the quarter decreased to $4.2 million from $5.5 million in the prior year, primarily due to lower milestone and ion channel service revenue.
Show less
Read more
Impact Snapshot
Event Time:
OABI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
OABI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
OABI alerts
High impacting OmniAb, Inc. news events
Weekly update
A roundup of the hottest topics
OABI
News
- OmniAb, Inc. (NASDAQ: OABI) had its "buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $8.00 price target on the stock.MarketBeat
- OmniAb, Inc. (NASDAQ: OABI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.MarketBeat
- OmniAb, Inc. (OABI) Q3 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- OmniAb, Inc. (OABI) Reports Q3 Loss, Lags Revenue Estimates [Yahoo! Finance]Yahoo! Finance
- OmniAb GAAP EPS of -$0.16 misses by $0.02, revenue of $4.2M misses by $4.2M [Seeking Alpha]Seeking Alpha
OABI
Earnings
- 11/12/24 - Miss
OABI
Sec Filings
- 11/12/24 - Form 10-Q
- 11/12/24 - Form 8-K
- 11/1/24 - Form 4
- OABI's page on the SEC website